Kemwell

Founded in 1980, Kemwell provides customized process/product development and manufacturing to biopharmaceutical organizations worldwide. Our facilities are located in Bangalore, India and were built with technical guidance from Boehringer Ingelheim, providing customers with state-of-the-art technology along with the benefit of cost-effective manufacturing.

The 15,000 sq. m. facility consist of a cGMP drug substance manufacturing facility with 2x2000L bioreactors and a sterile fill and finish facility for cGMP drug product manufacturing with a floor for process development laboratories to support production of protein therapeutics from mammalian-cell culture or microbial fermentation.

For over 30 years, Kemwell supported pharmaceutical companies with their development and manufacturing needs. We developed and manufactured drugs for some of the world’s top pharmaceutical companies including Bayer, GlaxoSmithKline, Merck KGaA, Novartis and Pfizer. In 2017, Kemwell sold its pharmaceutical business to Recipharm AB but continues to leverage its 30-year experience to provide biotech customers with cost-effective solutions.

  • Upstream development
  • Downstream development
  • Process charaterization
  • Scale-up studies

Learn More

  • Method development
  • Method validation
  • Reference standard charaterization
  • Stability studies

Learn More

  • Preformulation
  • Liq. & Lyo. formulations
  • Lyo. cycle development

Learn More

  • Mammalian cell culture
  • Monoclonal antibodies
  • Other recombinant proteins

Learn More

  • Liquid vials
  • Lyophilized vials

Learn More

Our Vision is to be the first-choice strategic partner for biopharmaceutical companies

Discover more about our Leadership team.

Visit Our Resource Center